Most Recent
US car giant Ford has partially succeeded in its challenge to a judgment that found it owed more than $6,800 to the lead applicant in a class action over defective PowerShift transmissions, but the High Court may ultimately decide how damages should be calculated under the Australian Consumer Law for reduction in value.
A judge has granted a bid for a new mediator in a class action over allegedly combustible cladding, agreeing with the applicant that a "fresh start" may be beneficial.
An investigation is underway against US medical device maker Exactech on behalf of patients who allegedly received faulty hip, knee or ankle implants.
A class action against Philips Electronics over recalled sleep apnea machines is likely to proceed with a new lead applicant and law firm after the solicitor on record decided the case was not viable.
Monsanto can't throw out the evidence of an expert for the plaintiff in a class action over its Roundup product who has testified that the company engaged in criminal conduct in trying to bury scientific reports on the popular weed killer's alleged cancer-causing properties.
The High Court has granted special leave to farmers in a class action against Advanta Seeds over allegedly contaminated product to challenge a court's finding that a disclaimer nullified the company's duty to protect growers against economic loss.
An Australian law firm is investigating a class action against drug manufacturers over a commonly prescribed antibiotic said to cause “disabling” side effects, including nerve damage and psychosis.
A former top judge appointed to decide the first-ever contest to administer a class action settlement has set out his criteria for making the choice, and has warned that giving the firm running a case a monopoly right to dole out the proceeds could lead to higher costs for group members and poorer settlement outcomes.
The runner-up in a contest to administer Johnson & Johnson's $300 million settlement of two pelvic mesh class actions has lost a challenge to a decision awarding the prize to the team of Slater & Gordon, BDO and the firm of former Shine Lawyers solicitor Jan Saddler.
A class action is being prepared on behalf of women who claim to have suffered complications from Allergan breast implants linked to a rare form of cancer.